OBIO Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03

Prezzo $5.95

Capitalizzazione di Mercato (MRQ) $358M

P/E (TTM) -7.2

EPS (TTM) $-0.83

Ricavi (TTM) $32M

ROE (TTM) -601.8%

Intervallo 52 sett. $3–$7

OBIO Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04

intervallo

barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06

Ricavi$33M

2022-12-31 → 2025-12-31

EPS$-1.11

2021-12-31 → 2025-12-31

Flusso di cassa libero$-49M

2023-12-31 → 2025-12-31

Margine netto-184.6%

2023-12-31 → 2025-12-31

Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica	OBIO	media 5 anni	Mediana dei peer	Verdetto
P/E (TTM)	-7.2media 5 anni ≈-104.2	≈-104.2	·	·
P/S (TTM)	11.2media 5 anni ≈49.0	≈49.0	5.5	Sopravvalutato
P/B (MRQ)	18.5media 5 anni ≈-0.8	≈-0.8	4.6	Sopravvalutato
Prezzo / FCF (TTM)	-6.1media 5 anni ≈-5.0	≈-5.0	·	·
Prezzo / Flusso di cassa (TTM)	-6.1media 5 anni ≈-41.6	≈-41.6	·	·
Price / Tangible Book (Prezzo / Valore contabile tangibile)	6.3media 5 anni ≈3.7	≈3.7	·	·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica	OBIO	media 5 anni	Mediana dei peer	Verdetto
Margine Operativo (TTM)	-181.4%media 5 anni ≈-1486.1%	≈-1486.1%	-58.4%	Debole
Margine EBITDA (TTM)	-180.3%media 5 anni ≈-1478.4%	≈-1478.4%	-58.4%	Debole
Margine di Profitto Netto (TTM)	-184.6%media 5 anni ≈-1416.8%	≈-1416.8%	-57.3%	Debole
ROA (TTM)	-74.5%media 5 anni ≈-36.1%	≈-36.1%	-32.6%	Debole
ROE (TTM)	-601.8%media 5 anni ≈-83.3%	≈-83.3%	-106.9%	Debole

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica	Tendenza 5 anni	OBIO	media 5 anni	Mediana dei peer	Verdetto
Rapporto corrente (MRQ)		8.3media 5 anni ≈5.9	≈5.9	4.9	Liquidità elevata
Quick Ratio (MRQ)		8.2media 5 anni ≈5.8	≈5.8	3.7	Liquidità elevata

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica	Tendenza 5 anni	OBIO	media 5 anni	Mediana dei peer	Verdetto
Revenue YoY (Ricavi YoY)		1169.2%media 5 anni ≈381.0%	≈381.0%	·	·
Revenue CAGR 3Y (CAGR Ricavi 3Y)		111.6%	·	·	·

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica	OBIO	media 5 anni	Mediana dei peer	Verdetto
EPS (Diluted) (EPS (Diluito))	$-1.11media 5 anni ≈$-1.30	≈$-1.30	·	·
Revenue / Share (Ricavi / Azione)	$0.70media 5 anni ≈$0.29	≈$0.29	·	·
Cash Flow / Share (Flusso di cassa / Azione)	$-1.03media 5 anni ≈$-0.97	≈$-0.97	·	·
Cash / Share (Liquidità / Azione)	$0.61media 5 anni ≈$0.50	≈$0.50	·	·

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica	OBIO	media 5 anni	Mediana dei peer	Verdetto
Asset Turnover (Rotazione delle attività)	0.4media 5 anni ≈0.1	≈0.1	0.6	Debole
Inventory Turnover (Rotazione delle scorte)	0.8media 5 anni ≈1.0	≈1.0	1.5	Debole
Receivables Turnover (Rotazione dei crediti)	358.1media 5 anni ≈138.0	≈138.0	6.6	Di prim'ordine
Revenue / Employee (Ricavi / Dipendente)	≈$389.3K	·	·	·

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14

Sorpresa media 18.1%

Prossimo report Nov 09, 2026

Periodo	Rapporto	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	Ago 18, 2026	$-0.38	$-0.40	5.0%
31 Marzo 2026	Mag 18, 2026	$-0.33	$-0.44	24.9%
31 Dicembre 2025		$-0.13	$-0.39	66.3%
30 Settembre 2025		$-0.40	$-0.44	9.8%
30 Giugno 2025		$-0.50	$-0.51	2.7%
31 Marzo 2025		$-0.49	$-0.49	0.12%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15

Conto Economico 15

Metrica	2025	2024	2023	2022
Revenue	$33M	$3M	$3M	$4M
Cost of Revenue	$190.0K	$204.0K	$186.0K	$211.0K
R&D Expense	$58M	$43M	$34M	$22M
SG&A Expense	$27M	$24M	$20M	$14M
Operating Expenses	$85M	$67M	$54M	$36M
Operating Income	$-52M	$-64M	$-52M	$-33M
Interest Income	·	·	·	$345.1K
Other Non-op	·	$-11.0K	·	·
Income Tax	$0	·	·	·
Net Income	$-53M	$-61M	$-49M	$-34M
EPS (Basic)	$-1.11	$-1.66	$-1.48	$-2.24
EPS (Diluted)	$-1.11	$-1.66	$-1.48	$-2.24
Shares (Basic)	47,747,078	36,821,042	33,225,227	14,988,584
Shares (Diluted)	47,747,078	36,821,042	33,225,227	14,988,584
EBITDA	$-51M	$-64M	$-51M	$-3M

Stato Patrimoniale 25

Metrica	2025	2024	2023	2022
Cash & Equivalents	$35M	$22M	$31M	$20M
Short-term Investments	$72M	$45M	$57M	$64M
Receivables	$95.0K	$92.0K	$99.0K	$96.0K
Inventory	$310.0K	$173.0K	$146.0K	$276.0K
Prepaid Expense	$994.0K	$2M	$1M	$533.0K
Current Assets	$108M	$69M	$89M	$85M
PP&E (Net)	$2M	$1M	$1M	$1M
PP&E (Gross)	$3M	$3M	$2M	$2M
Accum. Depreciation	$2M	$1M	$1M	$778.0K
Total Assets	$115M	$76M	$95M	$96M
Accounts Payable	$6M	$5M	$3M	$4M
Accrued Liabilities	$10M	$6M	$5M	$5M
Current Liabilities	$17M	$16M	$11M	$19M
Capital Leases	$936.0K	$2M	$1M	$2M
Deferred Tax	$393.0K	$561.0K	$508.0K	$637.0K
Other Non-current Liabilities	$308.0K	$40.0K	·	$196.0K
Total Liabilities	$51M	$43M	$27M	$43M
Long-term Debt	$15M	$15M	·	·
Common Stock	$6.0K	$4.0K	$4.0K	$2.0K
Paid-in Capital	$416M	$343M	$317M	$252M
Retained Earnings	$-363M	$-310M	$-249M	$-200M
AOCI	$60.0K	$52.0K	$-10.0K	$-8.0K
Stockholders' Equity	$54M	$33M	$68M	$53M
Liabilities + Equity	$115M	$76M	$95M	$96M
Shares Outstanding	57,032,963	38,194,442	35,777,412	20,187,850

Flusso di cassa 10

Metrica	2025	2024	2023	2022
D&A	$327.0K	$308.0K	$287.0K	$222.0K
Stock-based Comp	$12M	$11M	$8M	$3M
Other Non-cash	$-9M	$-457.0K	$-5M	·
Operating Cash Flow	$-49M	$-51M	$-46M	$-29M
CapEx	$489.0K	$289.0K	$78.0K	$591.0K
Investing Cash Flow	$-27M	$13M	$11M	$-64M
Net Debt Issued	·	·	$-11M	·
Financing Cash Flow	$88M	$29M	$46M	$103M
Net Change in Cash	$12M	$-8M	$11M	$10M
Free Cash Flow	$-49M	$-51M	$-46M	·

Redditività 5

Metrica	2025	2024	2023	2022
Operating Margin	-154.7%	-2437.5%	-1866.2%	·
Net Margin	-157.4%	-2313.3%	-1779.7%	·
EBITDA Margin	-153.8%	-2425.8%	-1855.8%	·
ROA	-55.2%	-71.2%	-51.5%	-2.4%
ROE	-195.7%	-154.2%	-66.5%	-10.0%

Liquidità e Solvibilità 2

Metrica	Tendenza	2025	2024	2023	2022
Current Ratio		6.4	4.3	8.0	0.2
Quick Ratio		6.4	4.1	7.8	0.1

Efficienza 3

Metrica	2025	2024	2023	2022
Asset Turnover	0.4	0.0	0.0	·
Inventory Turnover	0.8	1.3	0.9	·
Receivables Turnover	358.1	27.6	28.3	·

Per Azione 5

Metrica	2025	2024	2023	2022
Book Value / Share	$0.94	$0.86	$1.90	$-1.56
Revenue / Share	$0.70	$0.07	$0.08	·
Cash Flow / Share	$-1.03	$-1.37	$-1.39	$-0.10
Cash / Share	$0.61	$0.58	$0.85	$0.04
EPS (TTM)	$-1.11	$-1.66	$-1.48	$-2.24

Tassi di Crescita 2

Metrica	Tendenza	2025	2024	2023	2022
Revenue YoY		1169.2%	-4.4%	-21.9%	·
Revenue CAGR 3Y		111.6%	·	·	·

Valutazione (TTM) 10

Metrica	2025	2024	2023	2022
Revenue TTM	$33M	$3M	$3M	$4M
Net Income TTM	$-53M	$-61M	$-49M	$-34M
Market Cap	$237M	$153M	$327M	$44M
P/E	-3.7	-2.4	-6.2	-4.5
P/S	7.1	57.9	118.4	12.6
P/B	4.4	4.6	4.8	-6.4
P / Tangible Book	4.4	4.6	4.8	0.8
P / Cash Flow	-4.8	-3.0	-7.1	-28.1
P / FCF	-4.8	-3.0	-7.1	·
Earnings Yield	-26.8%	-41.5%	-16.2%	-22.4%

Conto Economico 14

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$88.0K	$110.0K	$31M	$861.0K	$836.0K	$868.0K	$253.0K	$987.0K	$778.0K	$620.0K	$262.0K	$419.0K	$915.0K	$1M	$1M	$1M
Cost of Revenue	$25.0K	$32.0K	$51.0K	$49.0K	$46.0K	$44.0K	$58.0K	$68.0K	$44.0K	$34.0K	$47.0K	$41.0K	$54.0K	$44.0K	$53.0K	$56.0K
R&D Expense	$17M	$16M	$17M	$14M	$14M	$13M	$11M	$12M	$11M	$9M	$9M	$9M	$8M	$8M	$8M	$6M
SG&A Expense	$6M	$6M	$7M	$7M	$6M	$6M	$6M	$6M	$6M	$6M	$4M	$6M	$5M	$4M	$3M	$5M
Operating Expenses	$22M	$22M	$24M	$21M	$20M	$20M	$17M	$17M	$18M	$15M	$13M	$15M	$14M	$13M	$11M	$11M
Operating Income	$-22M	$-22M	$7M	$-20M	$-19M	$-19M	$-17M	$-16M	$-17M	$-14M	$-12M	$-15M	$-13M	$-12M	$-10M	$-10M
Interest Expense	·	·	·	·	·	·	·	·	·	·	·	·	·	$351.0K	·	·
Other Non-op	·	·	·	·	·	·	$0	$0	$0	$-11.0K	·	·	·	·	·	·
Net Income	$-24M	$-21M	$6M	$-21M	$-19M	$-19M	$-16M	$-15M	$-16M	$-13M	$-13M	$-13M	$-12M	$-11M	$-10M	$-10M
EPS (Basic)	$-0.38	$-0.33	$0.28	$-0.40	$-0.50	$-0.49	$-0.42	$-0.41	$-0.45	$-0.38	$-0.35	$-0.38	$-0.35	$-0.40	$-0.34	$-0.51
EPS (Diluted)	$-0.38	$-0.33	$0.28	$-0.40	$-0.50	$-0.49	$-0.42	$-0.41	$-0.45	$-0.38	$-0.35	$-0.38	$-0.35	$-0.40	$-0.34	$-0.51
Shares (Basic)	63,812,098	62,721,869	·	52,186,503	38,392,716	38,235,409	·	37,621,495	35,800,273	35,777,877	·	35,243,598	34,613,466	27,643,549	·	20,187,773
Shares (Diluted)	63,812,098	62,721,869	·	52,186,503	38,392,716	38,235,409	·	37,621,495	35,800,273	35,777,877	·	35,243,598	34,613,466	27,643,549	·	20,187,773
EBITDA	$-22M	$-22M	·	$-20M	$-19M	$-19M	·	$-16M	$-17M	$-14M	·	$-15M	$-13M	$-11M	·	$-813.4K

Stato Patrimoniale 25

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$20M	$28M	$35M	$42M	$19M	$18M	$22M	$26M	$24M	$23M	$31M	$19M	$16M	$19M	$20M	$735.2K
Short-term Investments	$89M	$66M	$72M	$54M	$15M	$32M	$45M	$41M	$41M	$52M	$57M	$89M	$101M	$108M	$64M	·
Receivables	$51.0K	$84.0K	$95.0K	$52.0K	$83.0K	$89.0K	$92.0K	$115.0K	$80.0K	$67.0K	$99.0K	$86.0K	$171.0K	$76.0K	$96.0K	·
Inventory	$250.0K	$277.0K	$310.0K	$365.0K	$185.0K	$135.0K	$173.0K	$234.0K	$70.0K	$115.0K	$146.0K	$137.0K	$178.0K	$232.0K	$276.0K	·
Prepaid Expense	$977.0K	$1M	$994.0K	$2M	$2M	$2M	$2M	$1M	$1M	$1M	$1M	$1M	$1M	$2M	$533.0K	$137.3K
Current Assets	$111M	$96M	$108M	$98M	$36M	$52M	$69M	$69M	$66M	$76M	$89M	$110M	$120M	$130M	$85M	$872.6K
PP&E (Net)	$2M	$2M	$2M	$2M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	·
PP&E (Gross)	$4M	$4M	$3M	$3M	$3M	$3M	$3M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	·
Accum. Depreciation	$2M	$2M	$2M	$2M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$993.0K	$921.0K	$849.0K	$778.0K	·
Total Assets	$116M	$101M	$115M	$105M	$43M	$59M	$76M	$75M	$72M	$83M	$95M	$116M	$126M	$136M	$96M	$69M
Accounts Payable	$6M	$6M	$6M	$8M	$5M	$6M	$5M	$5M	$6M	$3M	$3M	$3M	$3M	$3M	$4M	$281.6K
Accrued Liabilities	$7M	$7M	$10M	$7M	$7M	$5M	$6M	$7M	$4M	$4M	$5M	$4M	$4M	$3M	$5M	$1M
Current Liabilities	$13M	$14M	$17M	$21M	$17M	$15M	$16M	$16M	$15M	$10M	$11M	$21M	$12M	$12M	$19M	$1M
Capital Leases	$520.0K	$730.0K	$936.0K	$1M	$1M	$2M	$2M	$1M	$1M	$1M	$1M	$1M	$1M	$2M	$2M	·
Deferred Tax	·	·	$393.0K	·	·	·	$561.0K	·	·	·	$508.0K	·	·	·	$637.0K	·
Other Non-current Liabilities	$397.0K	$367.0K	$308.0K	$248.0K	$189.0K	$99.0K	$40.0K	·	·	·	·	$266.0K	$213.0K	$249.0K	$196.0K	·
Total Liabilities	$86M	$50M	$51M	$61M	$43M	$42M	$43M	$29M	$28M	$25M	$27M	$37M	$36M	$37M	$43M	$7M
Long-term Debt	·	$15M	$15M	$15M	$15M	$15M	·	·	·	·	·	$10M	$10M	·	·	·
Common Stock	$6.0K	$6.0K	$6.0K	$6.0K	$4.0K	$4.0K	$4.0K	$4.0K	$4.0K	$4.0K	$4.0K	$4.0K	$4.0K	$3.0K	$2.0K	$445
Paid-in Capital	$426M	$424M	$416M	$413M	$348M	$345M	$343M	$340M	$322M	$320M	$317M	$316M	$312M	$310M	$252M	·
Retained Earnings	$-407M	$-383M	$-363M	$-369M	$-348M	$-329M	$-310M	$-294M	$-278M	$-262M	$-249M	$-236M	$-223M	$-211M	$-200M	$-6M
AOCI	$-81.0K	$-40.0K	$60.0K	$45.0K	$16.0K	$37.0K	$52.0K	$98.0K	$-23.0K	$-8.0K	$-10.0K	$-77.0K	$-96.0K	$-35.0K	$-8.0K	·
Stockholders' Equity	$19M	$41M	$54M	$44M	$295.0K	$17M	$33M	$46M	$44M	$57M	$68M	$80M	$89M	$100M	$53M	$-6M
Liabilities + Equity	$116M	$101M	$115M	$105M	$43M	$59M	$76M	$75M	$72M	$83M	$95M	$116M	$126M	$136M	$96M	$69M
Shares Outstanding	60,105,049	58,630,715	57,032,963	56,464,731	38,643,553	38,312,512	38,194,442	37,942,905	35,824,571	35,784,997	35,777,412	35,743,972	35,743,007	31,741,147	20,187,850	4,450,000

Flusso di cassa 9

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$96.0K	$90.0K	$82.0K	$81.0K	$81.0K	$83.0K	$84.0K	$76.0K	$74.0K	$74.0K	$72.0K	$71.0K	$73.0K	$71.0K	$70.0K	$54.0K
Stock-based Comp	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$2M	$3M	$3M	$919.0K	$4M	$2M	$1M	$863.0K	$2M
Other Non-cash	·	$-4M	·	·	·	$-909.0K	·	·	·	$-2M	·	·	·	$-5M	·	·
Operating Cash Flow	$-19M	$-22M	$-2M	$-15M	$-16M	$-17M	$-14M	$-14M	$-10M	$-13M	$-11M	$-10M	$-10M	$-14M	$-9M	$-20M
CapEx	$254.0K	$184.0K	$33.0K	$310.0K	$34.0K	$112.0K	$106.0K	$68.0K	$107.0K	$8.0K	$-3.0K	$19.0K	$27.0K	$35.0K	$54.0K	$224.0K
Investing Cash Flow	$-23M	$10M	$-18M	$-39M	$16M	$13M	$-4M	$557.0K	$10M	$6M	$33M	$13M	$8M	$-44M	$-63M	$-224.0K
Financing Cash Flow	$35M	$6M	$13M	$76M	$-428.0K	$-296.0K	$14M	$15M	$171.0K	$18.0K	$-11M	$4.0K	$86.0K	$57M	$-5M	$-2M
Net Change in Cash	$-8M	$-6M	$-7M	$23M	$401.0K	$-4M	$-3M	$2M	$389.0K	$-7M	$11M	$3M	$-2M	$-1M	$-77M	$88M
Free Cash Flow	·	$-22M	·	·	·	$-17M	·	·	·	$-13M	·	·	·	$-14M	·	·

Redditività 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-25404.5%	-20069.1%	·	-2359.2%	-2311.8%	-2179.8%	·	-1655.7%	-2167.0%	-2326.3%	·	-3466.3%	-1416.0%	-991.8%	·	·
Net Margin	-26994.3%	-18810.0%	·	-2419.1%	-2316.2%	-2160.7%	·	-1562.9%	-2054.0%	-2171.5%	·	-3178.0%	-1316.5%	-939.9%	·	·
EBITDA Margin	-25404.5%	-19987.3%	·	-2359.2%	-2311.8%	-2170.3%	·	-1655.7%	-2167.0%	-2314.3%	·	-3466.3%	-1416.0%	-985.7%	·	·
ROA	-30.0%	-25.9%	·	-23.1%	-33.6%	-26.5%	·	-16.1%	-16.1%	-12.3%	·	-14.4%	-8.4%	-7.3%	·	-0.59%
ROE	-242.2%	-71.3%	·	-46.3%	-87.2%	-50.7%	·	-24.5%	-23.9%	-17.2%	·	-36.2%	-28.6%	-22.9%	·	13.8%

Liquidità e Solvibilità 3

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	8.3	7.0	·	4.7	2.1	3.4	·	4.2	4.6	7.3	·	5.1	10.1	10.8	·	0.6
Quick Ratio	8.2	6.9	·	4.6	2.0	3.2	·	4.1	4.5	7.2	·	5.1	9.9	10.6	·	0.5
Interest Coverage	·	·	·	·	·	·	·	·	·	·	·	·	·	-32.9	·	·

Efficienza 3

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.0	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	·
Inventory Turnover	0.1	0.2	·	0.2	0.4	0.4	·	0.4	0.4	0.2	·	0.6	0.6	0.4	·	·
Receivables Turnover	1.3	1.3	·	10.3	10.3	11.1	·	9.8	6.2	8.7	·	9.7	10.7	30.6	·	·

Per Azione 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$0.32	$0.70	·	$0.77	$0.01	$0.44	·	$1.22	$1.23	$1.60	·	$2.23	$2.50	$3.14	·	$-1.36
Revenue / Share	$0.00	$0.00	·	$0.02	$0.02	$0.02	·	$0.03	$0.02	$0.02	·	$0.01	$0.03	$0.04	·	·
Cash Flow / Share	·	$-0.35	·	·	·	$-0.43	·	·	·	$-0.37	·	·	·	$-0.52	·	·
Cash / Share	$0.34	$0.48	·	$0.74	$0.49	$0.48	·	$0.67	$0.66	$0.65	·	$0.53	$0.46	$0.59	·	$0.17
EPS (TTM)	$-0.83	$-0.95	·	$-1.81	$-1.82	$-1.77	·	$-1.59	$-1.56	$-1.46	·	$-1.47	$-1.60	$-2.02	·	$-1.91

Valutazione (TTM) 9

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$32M	$33M	·	$3M	$3M	$3M	·	$3M	$2M	$2M	·	$4M	$4M	$4M	·	·
Net Income TTM	$-59M	$-55M	·	$-75M	$-70M	$-66M	·	$-58M	$-56M	$-52M	·	$-46M	$-43M	$-39M	·	$-24M
Market Cap	$259M	$249M	·	$140M	$104M	$164M	·	$195M	$292M	$189M	·	$312M	$250M	$621M	·	$44M
P/E	-5.2	-4.5	·	-1.4	-1.5	-2.4	·	-3.2	-5.2	-3.6	·	-5.9	-4.4	-9.7	·	-5.2
P/S	8.1	7.6	·	49.7	35.2	56.8	·	73.7	140.4	85.1	·	86.6	57.6	162.1	·	·
P/B	13.4	6.0	·	3.2	351.1	9.7	·	4.2	6.6	3.3	·	3.9	2.8	6.2	·	-7.3
P / Tangible Book	13.4	6.0	·	3.2	351.1	9.7	·	4.2	6.6	3.3	·	3.9	2.8	6.2	·	·
P / Cash Flow	·	-11.2	·	·	·	-9.9	·	·	·	-14.4	·	·	·	-43.2	·	·
Earnings Yield	-19.2%	-22.4%	·	-73.0%	-67.9%	-41.4%	·	-30.9%	-19.1%	-27.7%	·	-16.9%	-22.9%	-10.3%	·	-19.3%

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$33M	$3M	$3M	$4M	·
Margine Operativo %	-154.7%	-2437.5%	-1866.2%	·	·
Utile netto	$-53M	$-61M	$-49M	$-34M	$-378.8K
EPS Diluito	$-1.11	$-1.66	$-1.48	$-2.24	$-0.02

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Rapporto corrente	6.4	4.3	8.0	0.2	10.9
Quick Ratio	6.4	4.1	7.8	0.1	10.6

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-49M	$-51M	$-46M	·	·

Proprietari istituzionali (13F) 86 filer · $124.3M totale · Aggiornato al 30 Giugno 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 86

Valore detenuto $124.3M

Nuove posizioni 27

Posizioni chiuse 13

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
27 (+8 vs trimestre precedente)	13 (0 vs trimestre precedente)	22 (-2 vs trimestre precedente)	15 (+1 vs trimestre precedente)	+4.0M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
RTW INVESTMENTS, LP	$41.234.412	9.556.063	33,19%	Azioni
PERCEPTIVE ADVISORS LLC	$21.738.564	5.037.906	17,50%	Azioni
BlackRock, Inc.	$10.832.320	2.510.387	8,72%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$8.728.883	2.022.916	7,03%	Azioni
VANGUARD GROUP INC	$6.658.907	1.604.556	5,36%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$4.350.317	1.007.908	3,50%	Azioni
Alyeska Investment Group, L.P.	$4.315.000	1.000.000	3,47%	Azioni
Propel Bio Management, LLC	$3.869.265	896.701	3,11%	Azioni
STATE STREET CORP	$2.226.756	516.050	1,79%	Azioni
RICE HALL JAMES & ASSOCIATES, LLC	$1.829.560	424.000	1,47%	Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$1.508.282	349.544	1,21%	Azioni
NORTHERN TRUST CORP	$1.482.807	343.640	1,19%	Azioni
UBS Group AG	$1.405.711	325.773	1,13%	Azioni
VANGUARD FIDUCIARY TRUST CO	$1.261.072	292.253	1,01%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$1.186.508	274.973	0,95%	Azioni
Knott David M Jr	$1.094.504	253.651	0,88%	Azioni
Flat Footed LLC	$1.084.670	251.372	0,87%	Azioni
Simplify Asset Management Inc.	$946.655	219.387	0,76%	Azioni
GOLDMAN SACHS GROUP INC	$775.000	179.606	0,62%	Azioni
DAFNA Capital Management LLC	$547.319	126.841	0,44%	Azioni
AMH Equity Ltd	$411.680	166.000	0,33%	Azioni
RENAISSANCE TECHNOLOGIES LLC	$388.350	90.000	0,31%	Azioni
IFP Advisors, Inc	$386.659	89.608	0,31%	Azioni
Daytona Street Capital LLC	$379.336	96.398	0,31%	Azioni
Bank of New York Mellon Corp	$371.534	86.103	0,30%	Azioni
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$347.789	80.600	0,28%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$283.944	65.804	0,23%	Azioni
CITADEL ADVISORS LLC	$242.464	56.191	0,20%	Azioni
Nuveen, LLC	$224.889	52.118	0,18%	Azioni
Holos Integrated Wealth LLC	$204.316	51.595	0,16%	Azioni
Cubist Systematic Strategies, LLC	$193.172	77.892	0,16%	Azioni
NewEdge Advisors, LLC	$190.218	44.083	0,15%	Azioni
Y-Intercept (Hong Kong) Ltd	$187.642	43.486	0,15%	Azioni
DEUTSCHE BANK AG\	$171.383	39.672	0,14%	Azioni
XTX Topco Ltd	$167.482	38.814	0,13%	Azioni
WELLS FARGO & COMPANY/MN	$156.876	36.356	0,13%	Azioni
HighTower Advisors, LLC	$152.643	35.375	0,12%	Azioni
LASRY MARC	$150.955	60.869	0,12%	Azioni
Affinity Asset Advisors, LLC	$144.121	33.400	0,12%	Azioni
RHUMBLINE ADVISERS	$137.813	31.940	0,11%	Azioni
MORGAN STANLEY	$125.826	29.160	0,10%	Azioni
ALGERT GLOBAL LLC	$122.917	28.486	0,10%	Azioni
Meramec Financial Planners, LLC	$114.600	30.000	0,09%	Azioni
TWO SIGMA ADVISERS, LP	$112.465	27.100	0,09%	Azioni
AXQ CAPITAL, LP	$109.808	25.448	0,09%	Azioni
Invesco Ltd.	$106.533	24.689	0,09%	Azioni
MetLife Investment Management, LLC	$103.534	23.994	0,08%	Azioni
BANK OF AMERICA CORP /DE/	$102.792	23.822	0,08%	Azioni
JPMORGAN CHASE & CO	$99.181	20.880	0,08%	Azioni
TWO SIGMA INVESTMENTS, LP	$97.359	22.563	0,08%	Azioni

Mostra tutti i 86 proprietari istituzionali →

Attivisti e proprietari del 5%+ 3 partecipazioni

18

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante	Depositato	Partecipazione	Stato	Scopo	Deposito
RTW Investments, LP, RTW Master Fund, Ltd., RTW Innovation Master Fund, Ltd., Roderick Wong ×8 depositi	29 Aprile 2026	19,20%	Modifica	·	SEC
HSAC 2 Holdings, LLC ×3 depositi	07 Agosto 2024	·	Deposito iniziale	·	SEC
Geoffrey W. Smith	07 Febbraio 2023	·	Deposito iniziale	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Insider aziendali 21 insider · 11 dirigenti · 7 direttori

19

Insider	Ruolo	Ultima attività	Azioni possedute	Acquisti 12m	Vendite 12m	Netto 12m
David P Hochman	Chief Executive Officer and Chairperson	10 Settembre 2026 F	432.916	5	0	$149.150
Roderick Wong, M.D.	Chief Executive Officer	24 Gennaio 2023 P	2.808.512	0	0	$0
Andrew Lawrence Taylor	Chief Financial Officer	26 Agosto 2026 F	589.989	0	0	$0
Michael Kaswan	Chief Financial Officer	26 Gennaio 2023 A	162.574	0	0	$0
Darren Sherman	President and Chief Operating Officer	01 Ottobre 2026 S	1.119.402	1	5	$-342.290
Joshua Aiello	Principal Accounting Officer	26 Agosto 2026 F	18.441	0	0	$0
William Reed Little	Executive Vice President, Corporate Development & Strategy	30 Maggio 2024 P	307.859	0	0	$0
George Papandreou	General Manager and Senior Vice President, Focal Therapies	08 Maggio 2024 A	42.000	0	0	$0
Yuval Mika	General Manager and Chief Technology Officer, Bioelectronic Therapies	08 Maggio 2024 A	158.905	0	0	$0
Stephanie A Sirota	VP of Corp Stratege and Comm	04 Agosto 2020 P	20.000	0	0	$0
Alice Lee	VP Operations, Sec & Treasurer	04 Agosto 2020 P	10.000	0	0	$0
Connealy Pamela Yanchik	Direttore	23 Giugno 2026 A	66.038	0	0	$0
Jason Aryeh	Direttore	23 Giugno 2026 A	118.118	2	0	$37.481
Eric A Rose MD	Direttore	20 Giugno 2024 A	7.544	0	0	$0
Geoffrey Wade Smith	Direttore	20 Luglio 2023 A	20.913	0	0	$0
HSAC 2 Holdings, LLC	Proprietario del 10%	05 Agosto 2024 J	1.705.705	0	0	$0
Medtronic plc	Proprietario del 10%	30 Gennaio 2023 P	4.999.423	0	0	$0
Chris Cleary	·	12 Agosto 2026 F	29.153	0	0	$0
John Prosper Mack	·	12 Agosto 2026 F	66.544	0	0	$0
David Pacitti	·	12 Agosto 2026 F	54.750	0	0	$0
Eric S Fain	·	12 Agosto 2026 F	99.630	1	0	$82.600

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 10 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
IWC · iShares Trust	0,05%	135.778 SH	11 Settembre 2026	Giornaliero
IBBQ · Invesco Exchange-Traded Fund Trust …	0,03%	4.255 SH	02 Ottobre 2026	Giornaliero
IWO · iShares Trust	0,02%	374.286 SH	11 Settembre 2026	Giornaliero
VTWO · VANGUARD SCOTTSDALE FUNDS	0,01%	228.058 SH	19 Agosto 2026	Giornaliero
VTWG · VANGUARD SCOTTSDALE FUNDS	0,01%	42.916 SH	19 Agosto 2026	Giornaliero
IWM · iShares Trust	0,01%	815.602 SH	11 Settembre 2026	Giornaliero
RSSL · Global X Funds	0,01%	19.057 NS	31 Luglio 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,00%	498.632 SH	19 Agosto 2026	Giornaliero
VTI · VANGUARD INDEX FUNDS	0,00%	1.470.063 SH	19 Agosto 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	3.999 SH	19 Agosto 2026	Giornaliero

OBIO Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21

rating · 13 analisti COMPRA

Target mediano $11.00 +84,9%

3 23,1% Acquisto forte

8 61,5% Compra

2 15,4% Mantieni

0 0,0% Vendi

0 0,0% Vendita forte

Target Price a 12 Mesi

7 analisti · 2026-10-03

Target medio $12.43 +108,9%

← Sotto tutti i target Prezzo attuale $5.95

Basso$9.00 Media$12.43 Alto$20.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
OBIO	$237M	-3.7	1169.2%	-157.4%	-195.7%	·
SGHT	$424M	-10.7	-3.1%	-49.7%	-57.4%	86.2%
NPCE	$518M	-23.4	25.1%	-21.5%	-111.6%	77.2%
SI	$295M	-3.1	49.6%	-85.3%	-129.1%	76.5%
CARL	$329M	-5.8	85.9%	-58.7%	-375.2%	75.3%
OFIX	$604M	-6.5	2.9%	-11.2%	-20.3%	68.8%
CLPT	$402M	-15.2	17.8%	-69.1%	-106.9%	61.4%
CV	$501M	-10.4	15.3%	-186.8%	40.3%	52.9%
MOBI	·	·	·	·	·	·
ABT	$250.18B	33.7	5.7%	14.7%	13.1%	·

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares